LON:ROQ

Roquefort Therapeutics (ROQ) Share Forecast, Price & News

GBX 8.26

-0.24 (-2.82%)

(As of 05/27/2022 03:54 PM ET)

Add

Compare

Today's Range: 8.26
▼
8.49
50-Day Range: N/A
52-Week Range: 6
▼
13.63

Volume: 44,221 shs
Average Volume: 460,933 shs
Market Capitalization: £5.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive ROQ News and Ratings via Email

Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

About Roquefort Therapeutics

Roquefort Investments plc, an investment company, intends to acquire businesses focused on early-stage opportunities in the medical biotechnology sector. It focuses on drug and vaccine development, diagnostics, immuno-therapy, and cell and gene therapy areas. The company was incorporated in 2020 and is based in London, the United Kingdom.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:ROQ
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.roquefortinvest.com
Phone: 44 20 3290 9339
Fax: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 71,900,000
Free Float: N/A
Market Cap: £5.94 million
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Roquefort Therapeutics.

0.0 Community Rank

Outperform Votes
Roquefort Therapeutics has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Roquefort Therapeutics has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Roquefort Therapeutics and other stocks. Vote “Outperform” if you believe ROQ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ROQ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Roquefort Therapeutics does not currently pay a dividend.
Dividend Growth
Roquefort Therapeutics does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Roquefort Therapeutics insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Roquefort Therapeutics (LON:ROQ) Frequently Asked Questions

Who are Roquefort Therapeutics' key executives?: Roquefort Therapeutics' management team includes the following people:
Mr. Stephen Paul West B.Com, CA, Exec. Chairman & Company Sec. (Age 49)
Who are some of Roquefort Therapeutics' key competitors?: Some companies that are related to Roquefort Therapeutics include Liberty Biopharma (LTY), OptiBiotix Health (OPTI), ReNeuron Group (RENE), AorTech International (AOR), Hemostemix (HEM), NetScientific (NSCI), Oxford BioDynamics (OBD), Ensysce Biosciences (ENSC), IXICO (IXI), Bioasis Technologies (BTI), ImmuPharma (IMM), ValiRx (VAL), Quest PharmaTech (QPT), Hemogenyx Pharmaceuticals (HEMO) and Crescita Therapeutics (CTX).
View all of ROQ's competitors.
What is Roquefort Therapeutics' stock symbol?: Roquefort Therapeutics trades on the London Stock Exchange (LON) under the ticker symbol "ROQ."
How do I buy shares of Roquefort Therapeutics?: Shares of ROQ and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Roquefort Therapeutics' stock price today?: One share of ROQ stock can currently be purchased for approximately GBX 8.26.
How much money does Roquefort Therapeutics make?: Roquefort Therapeutics has a market capitalization of £5.94 million.
What is Roquefort Therapeutics' official website?: The official website for Roquefort Therapeutics is www.roquefortinvest.com.
How can I contact Roquefort Therapeutics?: The company can be reached via phone at 44 20 3290 9339.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.